During the past decade, Ziekenhuisgroep Twente conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 7 clinical trials were completed, i.e. on average, 15.6% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 4 clinical trials were completed. i.e. 17.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ziekenhuisgroep Twente" #1 sponsor was "Radboud University Medical Center" with 8 trials, followed by "The Netherlands Cancer Institute" with 7 trials sponsored, "Maastricht University Medical Center" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Borstkanker Onderzoek Groep" with 4 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ziekenhuisgroep Twente" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 7 trials as a collaborator, "Borstkanker Onderzoek Groep" with 4 trials as a collaborator, "Ziekenhuisgroep Twente" with 4 trials as a collaborator, "Bayer" with 3 trials as a collaborator and "Dutch Cancer Society" with 3 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Ziekenhuisgroep Twente" are "Breast Cancer" (8 trials), "Colorectal Cancer" (3 trials), "Heart Failure" (3 trials), "Prostatic Neoplasms" (3 trials) and "Abdominal Aortic Aneurysm" (2 trials). Many other conditions were trialed in "Ziekenhuisgroep Twente" in a lesser frequency.

Most popular intervention types in "Ziekenhuisgroep Twente" are "Drug" (38 trials), "Other" (14 trials), "Procedure" (10 trials), "Device" (8 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Enzalutamide" (3 trials), "Pembrolizumab" (3 trials), "Prednisone" (3 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ziekenhuisgroep Twente" are 52 trials for "All" genders, 10 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 37 active trials in "Ziekenhuisgroep Twente". 1 are not yet recruiting, 18 are recruiting, 16 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 25 completed trials in Ziekenhuisgroep Twente, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ziekenhuisgroep Twente, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".

Ziekenhuisgroep Twente has several departments that took part in Clinical trials: "Dept Internal Medicine, division of Nephrology Hospital Group Twente" - 2 trials